According to the CDC, diabetes is the most expensive chronic disease in the US, with $1 in every $4 spent on caring for people with the condition. With more than 11% of the population already having the disease and the prediction that 1 in every third American will develop it within their lifetime, diabetes is a national crisis.
Both economically and healthwise, finding better prevention measures and management plans for diabetes is in our best interest, and UAB Kilo Grupe might have a solution for both.
Klinio – The App For Better Diabetes Management
As a leader in digital health interventions, it isn’t a surprise that Kilo Health already offers an innovative solution for diabetes management in the form of the Klinio app.
The app opens with a quiz, specifically designed to individualize the experience for each user. And, with space to input health metrics, AI-driven trend analysis, and individualized solutions for every user, this app can truly revolutionize the way people with diabetes manage their condition.
It’s easy to use and can make communication with your doctor much easier. Klinio has also been developed with the help of diabetes experts. This ensures that all guidance on the app is based on scientific evidence and is actually helpful to users.
This kind of app-based intervention has many benefits for overall health and well-being, including being accessible, cost-effective, and engaging. In addition, studies, like this one published in JMIR Mhealth Uhealth in 2017, prove that digital diabetes apps improve patient outcomes, empower people with diabetes, and improve overall understanding of the condition.
The study explores the way the apps help people with diabetes, finding that they can support users to become more confident in dealing with their condition and can reduce the fear of not knowing what to do in a hypoglycemic episode.
But how does this app help to bring down the cost of diabetes care across the US?
Diabetes Costs for the Individual
On an individual level, an app like Klinio is hugely beneficial for the user. It can educate, guide, and help the user fully understand what their condition is and how they can better manage it.
Individualized care is also thought to have significant benefits for patient outcomes and improving adherence to diabetes treatment plans. This could have a huge impact on user management of their condition.
In terms of costs, it goes without saying that improvement in overall health will reduce healthcare costs and be more cost-effective in the long run. In addition, the Klinio app can be accessed easily by anyone with a smartphone, which is almost everyone these days.
Reducing Diabetes Costs for Businesses
Diabetes can have a profound impact on businesses. Not only do they have to pay extortionate costs for employee healthcare, but, according to the ADA, diabetes leads to increased absenteeism at the cost of $3.3 billion, and reduced productivity at the cost of $26.9 billion.
With these illuminating figures, it is in the best interest of businesses across the US to put specified interventions in place to support employees with type 2 diabetes and prediabetes. With the Kilo Health for Business scheme, they can do just that.
The Klinio app is part of this scheme and gives employees access to this highly effective diabetes management tool, helping them to take back control of their health, increasing productivity, and decreasing sick days.
The app helps users to stay in better health by offering an individualized diet program, exercise plans, and more. It can also tweak guidance based on health metrics to ensure that the program caters to the users up to date metrics.
Final Thoughts
Using monitoring apps and science-backed guidance helps people with diabetes to live healthier lives and better manage their condition. This, in turn, improves employee health and productivity. Diabetes is an incredibly costly chronic condition but UAB Kilo Grupe is working towards preventative measures and management tools that support lower diabetes care costs and better health for patients across the US.
